Evidence map›Paper›PMID 33097490›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2021

Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing

Suzanne P MacFarland, Jessica E Ebrahimzadeh, Kristin Zelley, Lubna Begum, Lee M Bass, Randall E Brand, Beth Dudley, Douglas S Fishman, Amanda Ganzak, Eve Karloski and 13 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Pediatric Cancer Screening in Hereditary Gastrointestinal Cancer Risk Syndromes: An Update from the AACR Childhood Cancer Predisposition Working Group.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. A NewDiagnostics (Basel, Switzerland) · 2022
    Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 1 country.

Suzanne P MacFarlandChildren's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Macfarlands@email.chop.edu bryson.katona@pennmedicine.upenn.edu.ORCID 0000-0001-5894-6403
Jessica E EbrahimzadehHospital of the University of Pennsylvania and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Kristin ZelleyChildren's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0003-0970-1850
Lubna BegumChildren's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Lee M BassAnn & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Randall E BrandDivision of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-4136-3313
Beth DudleyDivision of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-8464-6014
Douglas S FishmanTexas Children's Hospital and Baylor College of Medicine, Houston, Texas.
Amanda GanzakDepartment of Medicine and Cancer Center, Yale New Haven Hospital, Yale University, New Haven, Connecticut.
Eve KarloskiDivision of Gastroenterology, Hepatology, and Nutrition, University of Pittsburgh, Pittsburgh, Pennsylvania.ORCID 0000-0002-2916-0425
Alicia LathamMemorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.ORCID 0000-0002-9758-713X
Xavier LlorDepartment of Medicine and Cancer Center, Yale New Haven Hospital, Yale University, New Haven, Connecticut.ORCID 0000-0002-6259-185X
Sharon PlonTexas Children's Hospital and Baylor College of Medicine, Houston, Texas.
Mary K RiordanAnn & Robert H. Lurie Children's Hospital of Chicago and Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Sarah R ScollonTexas Children's Hospital and Baylor College of Medicine, Houston, Texas.ORCID 0000-0003-2017-0245
Zsofia K StadlerMemorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York.
Sapna SyngalDana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0001-5487-7471
Chinedu UkaegbuDana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
Jennifer M WeissUniversity of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.ORCID 0000-0002-4927-2133
Matthew B YurgelunDana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-6184-9273
Garrett M BrodeurChildren's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0002-6721-122X
Petar MamulaChildren's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Bryson W KatonaHospital of the University of Pennsylvania and University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Macfarlands@email.chop.edu bryson.katona@pennmedicine.upenn.edu.ORCID 0000-0001-8186-9119
Children's Hospital of Philadelphia · USTexas Children's Hospital · USUniversity of Pittsburgh · USBrigham and Women's Hospital · USHospital of the University of Pennsylvania · USMemorial Sloan Kettering Cancer Center · USNorthwestern University · USYale New Haven Hospital · USDana-Farber Cancer Institute · USWisconsin Division of Public Health · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Menin/MLL promotes cell survival in the setting of EGFR inhibitionK08DK106489 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATONA, BRYSON WILLIAM · 2015 to 2019
$819k
Menin regulates colonic epithelial cell growth through LXR repressionR03DK120946 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATONA, BRYSON WILLIAM · 2019 to 2020
$243k
NCI NIH HHS P30 CA008748NIDDK NIH HHS K08 DK106489NIDDK NIH HHS R03 DK120946
6 · The paper itself

Abstract

Juvenile polyposis syndrome (JPS) is a clinically diagnosed hamartomatous polyposis syndrome that increases the risk of gastrointestinal cancer. Approximately 40%-50% of JPS is caused by a germline disease-causing variant (DCV) in the

Indexed as

AdolescentAdultAgedAge FactorsBone Morphogenetic Protein Receptors, Type IChildChild, PreschoolColectomyColonoscopyFemaleFollow-Up StudiesGerm-Line MutationHumansIntestinal PolyposisMaleMedical History TakingBMPR1A protein, humanBone Morphogenetic Protein Receptors, Type ISmad4 ProteinSMAD4 protein, human

Identifiers

PMID33097490
PMCPMC8557953
OpenAlexW3094358036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.